| Dr Peter Vaneerden, MD, MS | |
|
801 Broadway N, Fargo, ND 58122 | |
| (701) 234-2241 | |
| (701) 234-4877 |
| Full Name | Dr Peter Vaneerden |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851397509 | NPI | - | NPPES |
| 6201360 | Medicaid | SD |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
| Sanford Health Of Northern Minnesota | 5597725168 | 258 |
News Archive
A federal judge ruled Monday that Arizona's ban on most abortions after 20 weeks of pregnancy can stand. The judge said the law doesn't stop women from getting abortions, but that it may make some women consider the procedure earlier in their pregnancies.
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
According to a study published on June 1 in Nature Communications, differences in the uptake of multiple toxic and essential elements over the second and third trimesters and in the early postnatal periods of pregnancy are connected with the risk of developing autism spectrum disorders (ASDs).
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.
A new stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, based on one-year results of the first human trial using this stent reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 7 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
A federal judge ruled Monday that Arizona's ban on most abortions after 20 weeks of pregnancy can stand. The judge said the law doesn't stop women from getting abortions, but that it may make some women consider the procedure earlier in their pregnancies.
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
According to a study published on June 1 in Nature Communications, differences in the uptake of multiple toxic and essential elements over the second and third trimesters and in the early postnatal periods of pregnancy are connected with the risk of developing autism spectrum disorders (ASDs).
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.
A new stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, based on one-year results of the first human trial using this stent reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 7 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
A federal judge ruled Monday that Arizona's ban on most abortions after 20 weeks of pregnancy can stand. The judge said the law doesn't stop women from getting abortions, but that it may make some women consider the procedure earlier in their pregnancies.
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
According to a study published on June 1 in Nature Communications, differences in the uptake of multiple toxic and essential elements over the second and third trimesters and in the early postnatal periods of pregnancy are connected with the risk of developing autism spectrum disorders (ASDs).
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.
A new stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, based on one-year results of the first human trial using this stent reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Vaneerden, MD, MS Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Dr Peter Vaneerden, MD, MS 801 Broadway N, Fargo, ND 58122 Ph: (701) 234-2241 |
News Archive
A federal judge ruled Monday that Arizona's ban on most abortions after 20 weeks of pregnancy can stand. The judge said the law doesn't stop women from getting abortions, but that it may make some women consider the procedure earlier in their pregnancies.
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
According to a study published on June 1 in Nature Communications, differences in the uptake of multiple toxic and essential elements over the second and third trimesters and in the early postnatal periods of pregnancy are connected with the risk of developing autism spectrum disorders (ASDs).
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.
A new stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, based on one-year results of the first human trial using this stent reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 7 days ago
Zena Kay Homan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Jeffrey Allen Rondeau, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2400 32nd Ave S, Fargo, ND 58103 Phone: 701-234-8880 Fax: 701-234-8995 | |
Christine Keup, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 | |
Dr. John Michael Balintona, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Margaret Traynor Mickelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 Fax: 701-234-4877 | |
Dr. Denise M Schumacher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4450 31st Ave S Ste 102, Fargo, ND 58104 Phone: 012-802-0337 Fax: 701-232-5578 | |
Walter C Bro, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-4877 |